Carotid intima-media thickness of young coronary patients

Coronary Artery Disease

Volumn 10, Issue 6, 1999, Pages 407-411

  Vrtovec, Bojan ^a,b   Keber, Irena ^a   Gadzijev, Andrej ^a   Bardorfer, Igor ^a   Keber, Dusan ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

B mode ultrasonography; Carotid artery atherosclerosis; Coronary artery disease

Indexed keywords

FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LIPOPROTEIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; TRANSFERRIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; IRON BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

EID: 0032873788     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199909000-00010     Document Type: Article

References (31)

1. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis - a multifactioral disease. Atherosclerosis 1993; 3:3-16.
2. Pearson TA, Heiss GM. Atherosclerosis - quantitative imaging, risk factors, prevalence, and change. Atherosclerosis 1993; 3:2.
3. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological comparison of the human arterial wall: verification of intima-media thickness. Arterioscler Thromb 1993; 13:482-486.
4. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles, and description of a computerized analyzing system. Clin Physiol 1991; 11:565-577.
5. Gnasso A, Irace C, Mattioli PL, Pujia A. Carotid intima-media thickness and coronary heart disease risk factors. Atherosclerosis 1996; 119:7-15.
6. Crouse JR. Carotid and coronary atherosclerosis - what are the connections? Atherosclerosis 1991; 3:175-179.
7. Sanguigni V, Gallu M, Strano A. Incidence of carotid artery atherosclerosis in patients with coronary artery disease. Angiology 1993; 44:34-38.
8. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam study. Circulation 1997; 96:1432-1437.
9. Glagov S, Bassiouny HS, Giddens DP, Zarins CK. Intimal thickening: morphogenesis, functional significance and detection. J Vasc Investig 1995; 1:2-14.
10. World Health Organization Task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59:607-608.
11. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1970; 20:470-475.
12. Fossati P, Prencipe L. Serum triglycerides determined colormetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28:2077-2080.
13. Warnick GR, Benderson J, Albers JJ. Dextran sulfate Mg precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982; 28:1370-1388.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
15. Ranby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentration in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32:2160-2165.
16. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71:220-225.
17. Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple and sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48:266-269.
18. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984; 51:392-395.
19. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17:237-246.
20. Passey RB, Gillum RL, Fuller JB. Evaluation and comparison of ten glucose methods and the reference method recommended in the proposed product class standard. Clin Chem 1972; 18:499-502.
21. Persijn JP, Van der Silk W, Riethorst A. Determination of serum iron and latent iron-binding capacity (LIBC). Clin Chem Acta 1971; 35:91-98.
22. Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart 1996; 76:321-325.
23. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87:56-65.
24. Blankenhorn DH, Hodis HN. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 1994; 14:177-192.
25. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation 1990; 82:1230-1242.
26. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8:788-792
27. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis 1988; 70:253-261.
28. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation 1995; 91:284-290.
29. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996; 94:2057-2063.
30. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 1993; 70:138-143.
31. Salonen JT. The role of iron as a cardiovascular risk factor. Curr Opin Lipidol 1993; 4:277-282.